MedAvail Holdings Inc. sell dimontalban
Start price
11.04.22
/
90%
€1.98
Target price
11.04.23
€0.000
Performance (%)
-5.05%
End price
02.05.22
€1.88
Summary
This prediction ended on 02.05.22 with a price of €1.88. With a performance of -5.05%, the SELL prediction by dimontalban was trending in the right direction. dimontalban has 90% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MedAvail Holdings Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to dimontalban what are the pros and cons of MedAvail Holdings Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Normal challenges to pay loans and raise capital
Good culture
Sustainability is important
Cons
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
High valuation
Very low/no dividend yield expected
very negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
ROE lower than 5% per year
Below average Management
No Innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
High risks for its business
Below average Marketposition
high free float
Significant cyclical dependencies
Business model of the past or high risk
Unknown brand
Bad rating
Comments by dimontalban for this prediction
In the thread MedAvail Holdings Inc. diskutieren
Sell mit Kursziel 0,0
In the thread Trading MedAvail Holdings Inc.
Stopped prediction by dimontalban for MedAvail Holdings Inc.
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.88
02.05.22
02.05.22
€32.00
02.05.23
02.05.23
-24.47%
02.06.22
02.06.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
